Abstract 4958: VTP50469 is a novel, orally available menin-MLL1 inhibitor effective againstMLL-rearranged and NPM1-mutant leukemia
Experimental and Molecular Therapeutics(2018)
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
Experimental and Molecular Therapeutics(2018)